The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency’s work affects Americans’ health and safety.

Guests

  • Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
  • Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
  • Marc Kaufman reporter on the national desk of "The Washington Post"
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sandra Kweder deputy director of the FDA's Office of New Drugs

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, May 20 2016The latest on the crash of the Egypt Air passenger plane. ISIS ramps up its bombings in Baghdad. And Nigerian authorities say two of the missing schoolgirls captured by Boko Haram have been found. A panel of journalists joins guest host Allison Aubrey for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, May 20 2016Donald Trump unveils his proposed Supreme Court nominees. Bernie Sanders tells the Democratic Party to "let the people in." And the federal government promises action to fight long airport security delays. A panel of journalists joins guest host Allison Aubrey of NPR News for analysis of the week's top national news stories.